Incidence and recurrence of acute otitis media in Taiwan's pediatric population by Wang, Pa-Chun et al.
CLINICAL SCIENCE
Incidence and recurrence of acute otitis media in
Taiwan’s pediatric population
Pa-Chun Wang,I,II,III Ya-Hui Chang,IV Li-Ju Chuang,V Hui-Fang Su,VI Chung-Yi LiIV
IDepartment of Otolaryngology, Cathay General Hospital, Taipei, Taiwan. II Fu Jen Catholic University School of Medicine, Taipei County, Taiwan.
IIIDepartment of Public Health, College of Public Health, China Medical University, Taichung, Taiwan. IVDepartment of Public Health, College of Medicine,
National Cheng Kung University, Tainan, Taiwan. VCathay Medical Research Institute, Taipei County, Taiwan. VIDepartment of Health Care Management,
National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.
OBJECTIVE: To report the incidence and recurrence of acute otitis media (AOM) in Taiwan’s pediatric population.
METHODS: Information from children (aged,=12 years) with a diagnosis of AOM was retrieved from the 2006
National Healthcare Insurance claims database. We calculated the cumulative incidence rate and the incidence
density rate of recurrent AOM within one year after the initial diagnosis in 2006. We used a multivariate logistic
regression model to assess the predictors for recurrence of AOM.
RESULTS: The annual incidence rate of AOM was estimated to be 64.5 cases per 1,000 children. The overall one-year
cumulative incidence rate of recurrence was 33.1%, and the incidence density rate was 33.5 cases per 100 person-
years, with the highest figure (41.2 cases per 100 person-years) noted for children aged 0-2 years. Recurrence was
significantly associated with age, gender, place of treatment, and physician specialty.
CONCLUSION: AOM remains a major threat to children’s health in Taiwan. Male children and very young children
require more aggressive preventive strategies to reduce the risk of recurrence.
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INTRODUCTION
Otitis media is defined as infection in the middle ear.
Acute otitis media (AOM) is one of the most common
infections in children under 15 years of age.1 AOM can
cause serious symptoms such as fever, otalgia, and otorrhea,
all of which may be associated with the use of considerable
medical resources. Otitis media with effusion (OME)
resulting from AOM can impair hearing, affecting children’s
school performance and speech development. In general,
AOM can disrupt a child’s daily activities and have a
profound negative impact on the quality of life.2-4
AOM is a disease that is prevalent in the pediatric
population. Prevention and management of AOM are
important from a public health point of view. To improve
clinical care and properly allocate medical resources, the
medical community must know the epidemiological char-
acteristics of AOM. Although the recent US National Health
Interview Survey described declining rates of AOM
occurrence, antibiotic prescriptions, office visits for AOM,
and middle ear surgery since the licensure and routine use
of the pneumococcal conjugate vaccine in infants, the panel
report also recommended more research on otitis media to
further reduce AOM incidence.5
Although mounting data concerning the prevalence and
incidence of AOM are available in epidemiological studies,
the comparison and extrapolation of epidemiological data
from these studies is difficult, if not impossible, mainly due
to dissimilarities in study design, sampling methodology,
and diagnostic consistency.2-4 Although the threat that
AOM poses to children has been well recognized, limited
information is available concerning the nationwide inci-
dence and recurrence of AOM in Taiwan’s pediatric
population. Using the 2006-2007 National Health
Insurance (NHI) claims database, this study sought to
investigate the epidemiological characteristics of pediatric
AOM in Taiwan. We also aimed to identify the pediatric
AOM patients who are at a greater risk of recurrence.
METHODS
Source of Data
A universal NHI program, which is administered by the
Bureau of NHI (BNHI) under the jurisdiction of the
Department of Health, was implemented in Taiwan in
March 1995. Approximately 96% of the Taiwanese popula-
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tion enrolled in the NHI program,6 and the state-run BNHI
had contracted with 97% of hospitals and 90% of clinics all
over the country by the end of 1996.7 The BNHI accumulates
all administrative and claims data, and the National Health
Research Institute (NHRI) cooperates with the BNHI to
maintain an NHI research database. The NHRI protects the
privacy and confidentiality of all beneficiaries and transfers
the health insurance data to health researchers after ethical
approval has been obtained. To ensure the accuracy of the
claim files, the BNHI performs expert reviews on a random
sample of every 50-100 ambulatory and inpatient claims in
each hospital and clinic quarterly, and false reports of
diagnosis receive a severe penalty from the BNHI.8 In this
study, we used data from the ambulatory care claims (2006-
2007) and inpatient claims (2006-2007) and updated registry
for beneficiaries (2007). All NHI datasets can be linked with
each individual’s personal identification number (PIN). The
study was approved by the IRB of the Cathay General
Hospital.
Study Design and Cohort
This study aimed to estimate the recurrent rate of AOM in
Taiwan’s child population and to identify the groups at high
risk of recurrence. To meet these goals, we adopted a cohort
study design. The study cohort consisted of all 283,084
children who had ambulatory care visits or were hospita-
lized with a primary or secondary diagnosis of AOM
(International Classification Code 9th version Clinical
Modification (ICD-9-CM): 381.xx or 382.xx) between
January 14 and December 31, 2006. The dates of their first-
time ambulatory care visit or hospitalization in 2006 were
set as the baseline (initial) AOM attack. Baseline information
was retrieved from claims data, including the patient’s date
of birth, gender, place of care (clinics, district or regional
hospitals, medical centers), and the specialty of the attend-
ing physician. The age of the study subjects was calculated
as the difference between the date of the baseline attack and
the date of birth.
Data Linkage and Definition of Recurrence
With their unique PINs, the individuals who comprised
the study cohort could be linked to the 2006-2007 ambula-
tory care and inpatient claims to identify the possible
recurrence of AOM within 12 months following the baseline
attack. Only subsequent ambulatory care visits (or hospita-
lizations) with a primary or secondary diagnosis of AOM
and with a date of ambulatory care visit (or hospitalization)
at least 15 days apart from the previous AOM ambulatory
care visit (or hospitalization) were considered new episodes
(i.e., recurrence). Using the 2007 updated registry for
beneficiaries, we were able to calculate the person-years
(PYs) for which each study subject had been observed from
the baseline attack either to the date of termination of the
NHI policy (primarily due to death) or to the 365th day.
Statistical Analysis
Characteristics of the study cohort were first assessed. We
then calculated the cumulative incidence rate (CIR) and
incidence density rate (IDR) per 100 PYs for AOM within
one year of follow-up, according to various subjects’
characteristics. The IDR was calculated as the ratio of the
total number of AOM recurrences (i.e., frequency) to the
total number of PYs observed. Last, we used a multivariate
logistic regression model to assess the independent effects
of age, gender, place of treatment, and physician specialty
on the risk of 1-year AOM recurrence. All statistical analyses
were performed with SAS (version 9.1; SAS Institute, Cary,
NC). p ,0.05 was considered statistically significant.
RESULTS
In 2006, a total of 283,084 children ,= 12 years of age
sought treatment for AOM, representing an annual inci-
dence rate of 64.5 cases per 1,000 children (283,084/
4,385,779). The age-specific annual incidence rates for
children aged 0-2 years, 3-5 years, and 6-12 years were
71.7, 158.8, and 41.0 per 1,000 children, respectively. Male
children had a higher incidence rate than females (67.6 vs.
61.2 per 1,000) (data not shown in tables). Table 1 shows the
characteristics of both the baseline episodes of AOM in 2006
and all episodes in one year including baseline attacks and
recurrent episodes. The mean (¡standard deviation (SD))
age was 4.7 (¡2.8) years for the patients at baseline, and
male patients predominated (54.6% vs. 45.4%). Additionally,
most (73.4%) baseline episodes were treated at clinics.
Nearly 80% of the patients were treated by either otolar-
yngologists (32.2%) or pediatricians (46.3%). The distribu-
tions of the selected variables were almost the same after
inclusion of all recurrent episodes during the study period.
The overall IDR of recurrence for the study cohort was
33.5 per 100 PYs, with the highest IDR of 41.2 per 100 PYs
noted for the patients aged 0-2 years. The IDR decreased to
38.1 per 100 PYs and 26.7 per 100 PYs for those aged 3-5 and
6-12 years, respectively. The recurrence rate was slightly
higher in male patients than in female patients (34.4 vs. 32.5
per 100 PYs). Additionally, the recurrence rate varied
slightly (32.7-34.4 per 100 PYs) by place of treatment.
Higher IDRs were also noted in patients treated by
otolaryngologists (34.0 per 100 PYs) and pediatricians (34.7
per 100 PYs) (Table 2).
Table 1 - Characteristics of the baseline acute otitis media
episodes in 2006.
Baseline episodes in 2006 (N=283,084)
Variables a n %
Age (years)
0-2 43,404 15.3
3-5 114,040 40.3
6-12 125,640 44.4
Mean (¡SD) 4.7 (¡2.8)
Gender
Male 154,692 54.6
Female 128,390 45.4
Place of treatment
Clinics 207,762 73.4
Hospital
Medical center 21,709 7.7
District hospital 33,614 11.9
Regional hospital 19,999 7.1
Specialty of attending physician
Ear, nose, and throat 91,061 32.2
Pediatrics 131,001 46.3
Family medicine 14,548 5.1
Internal medicine 3,906 1.4
Surgery 197 0.1
Others 42,371 15.0
aInconsistency between total population and population summed for
individual variable was due to missing information.
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Table 3 shows the adjusted odds ratios (ORs) associated
with the risk of recurrence in relation to the selected
variables of interest. Compared with those aged 0-2 years,
the patients aged 3-5 years (OR= 0.87, 95% CI = 0.85-0.89)
and 6-12 years (OR= 0.51, 95% CI = 0.50-0.52) had signifi-
cantly reduced odds of recurrence. Female patients also had
significantly lower odds of recurrence than male patients
(OR= 0.92, 95% CI = 0.91-0.94). Additionally, compared with
those treated at clinics, patients treated in medical centers
(OR= 0.95) and district/regional hospitals (OR= 0.90) had
significantly reduced odds of recurrence. Moreover, the
patients treated by otolaryngologists (OR= 1.25, 95%
CI = 1.21-1.28), pediatricians (OR=1.16, 95% CI = 1.13-1.18),
and family medicine physicians (OR=1.08, 95% CI = 1.03-
1.13) all had significantly increased odds of recurrence.
DISCUSSION
Epidemiological Characteristics in General and in
Taiwan
AOM is a public health concern in the pediatric
population because of its high incidence and serious
adverse outcomes. Although the direct costs of diagnosis
and treatment for a single episode of AOM are not
tremendously high, the indirect costs associated with health
care for recurrent AOM, AOM-related complications, and
parental absence from work to care for the children can be
substantial.1 Some epidemiological data are currently
available in the literature. Alho et al. reported that the
incidence of AOM was 0.93 incidents per child-year during
the first 24 months of life.2 Stangerup et al. estimated that
the prevalence of AOM was fairly constant at about 25%
during the first 5 years of life.3 Teele et al., in a prospective
cohort study on children from the greater Boston area,
reported that by the end of the first year after birth, 62% of
children had at least 1 episode of AOM; by the end of the
third year of life, the proportion had increased to 83%, and
the peak incidence occurred during the first 6 months of
life.4 Previous studies have also indicated that most children
may experience at least 1 episode of AOM during their
childhood; between 10% and 62% of children had at least 1
episode of AOM by the age of 1 year.1,4,9,10 Pukander et al.
reported an annual incidence rate of AOM of 4.44% in the
pediatric population of 2 Finnish towns.11 Our data were
generally compatible with these previous studies. We found
that in Taiwan, 64.5 per 1,000 children aged 12 or younger
may have experienced at least 1 episode of AOM in a year.
Limited epidemiological data on AOM are currently
available in Taiwan. Chen et al. examined 3,013 Ethnic
Chinese children (aged 3-6 years) from 19 daycare centers in
Kaoshiung City,12 the largest city in southern Taiwan, and
estimated that the prevalence rate of otitis media was
9.82%.11 However, this cross-sectional survey did not
specify the actual prevalence of acute middle ear infection.
Parnn et al. identified a total of 119,773 cases of AOM (ICD-
9-CM codes: 381.0, 381.4, 382.0, 382.4, and 382.9) from the
2001 NHI database, and most of the cases were under 5
years of age.13 Parnn et al.’s nationwide study focused on
patients’ medical utilization and provided limited informa-
tion on overall and specific rates of prevalence and
recurrence. Moreover, the diagnostic codes employed by
Parnn et al. to identify AOM were considered inadequate
for identification of all AOM patients.13
Effect of Age
It is generally agreed that the risk of AOM may decrease
with advanced age during childhood. The peak incidence
rate of AOM is normally found to occur during the second
half of the first year in most studies.2-4,14 Alho et al.
estimated that the CIR of the first episode of AOM was
42.4% (95% CI 40.4-44.4) up to the age of 1 year;2 Stangerup
et al. reported an incidence rate of 22%, 15%, 10%, and 2% at
the age of 1 year, 2 years, 3-4 years, and 8 years,
Table 2 - Incidence density rate of recurrence of acute
otitis media within a one-year period following the
baseline attack in 2006 (N=283,084).
No. of person-
years
No. of recurrent
episodes
Incidence
density rate
(per 100
person-years
Age (years)
0-2 42,776 17,627 41.2
3-5 11,2674 42,983 38.1
6-12 124,557 33,226 26.7
Gender
Male 153,014 52,577 34.4
Female 126,993 41,259 32.5
Place of treatment
Clinics 205,757 69,010 33.5
Hospital
Medical center 21,387 7,198 33.7
District hospital 33,143 10,844 32.7
Regional hospital 19,720 6,784 34.4
Specialty of attending
physician
Ear, nose, and throat 90,217 30,640 34.0
Pediatrics 129,391 44,861 34.7
Family medicine 14,396 4,801 32.0
Internal medicine 3,869 1,177 30.4
Surgery 194 61 31.5
Others 41,940 12,496 29.8
Total 280,007 93,836 33.5
Table 3 - Predictors for recurrent episodes of acute otitis
media (N=283,084 ).
Recurrence Adjusted odds ratio
n % Estimate 95% CI
Age (years)
0-2 17,627 40.6 1.00
3-5 42,983 37.7 0.87 (0.85-0.89)
6-12 33,226 26.4 0.51 (0.50-0.52)
Gender
Male 52,577 34.0 1.00
Female 41,259 32.1 0.92 (0.91-0.94)
Place of treatment
Clinics 69,010 33.2 1.00
Hospital
Medical center 7,198 33.2 0.95 (0.92-0.98)
District hospital 10,844 32.3 0.90 (0.88-0.93)
Regional hospital 6,784 33.9 0.97 (0.94-1.00)
Specialty of attending
physician
Others 12,496 29.5 1.00
Ear, nose, and throat 30,640 33.6 1.25 (1.21-1.28)
Pediatrics 44,861 34.2 1.16 (1.13-1.18)
Family medicine 4,601 33.0 1.08 (1.03-1.13)
Internal medicine 1,177 30.1 1.06 (0.99-1.14)
Surgery 61 31.0 1.18 (0.87-1.60)
Total 93,836 33.1
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respectively.3 Our data showed a peak incidence in children
aged 3-5 years. This finding is compatible with data from
other local pneumococcal studies in Taiwan. A recent study
by Wu et al. reported that the peak prevalence of invasive
pneumococcal diseases (lobar pneumonia and empyema)
was in children aged 4-5 years.15 Another possible explana-
tion for our finding was that many children who sought care
for AOM at age 3-5 years actually incurred this disease at
earlier ages. Regarding recurrence, our data were compa-
tible with other studies showing that the odds of recurrence
decline with age (IDRs of 41.2 per 100 PYs for age 0-2 years,
38.1 per 100 PYs for age 3-5 years, and 26.7 per 100 PYs for
age 6-12 years).
Effect of Gender
Previous studies reached inconsistent conclusions on the
effect of gender on the risk of AOM.3,4,9,10,14 Teele et al.4 and
Sipila et al.14 found that male gender was a risk factor for
AOM. In contrast, Stangerup et al.,3 Homoe et al.,10 and
Lundgren et al.9 all concluded that no gender differences
were found in the incidence and prevalence of AOM. Our
national sample showed that more male than female
children (54.6% vs. 45.4%) suffered from AOM at baseline,
and the incidence rate of AOM in 2006-2007 was also higher
in male children than in their female counterparts (67.6 vs.
61.2 per 1,000). Additionally, male children were more likely
than female children to have recurrent AOM (34.4 vs. 32.5
per 1,000 PYs). The plausible mechanisms contributing to
the effect of gender on the incidence of AOM have not yet
been identified.
Recurrence
AOM is prone to recurrence, and this phenomenon has
long been a target of research. Traditionally, initial AOM
attack at an earlier age, comorbid airway infection, sibling
AOM history, bottle feeding, and daycare condition have
been considered risk factors for recurrent AOM.4,16-18 The
recurrence rates reported in previous studies range from
20%- 27% in 6 months16,18 to 60% in 4 months.19 Our data
showed a recurrence rate of 33.5% in one year in Taiwan’s
pediatric population, which is somewhat lower than the
findings from previous reports. We also found that younger
age (0-2 years), male gender, and treatment in clinics were
all associated with significantly higher recurrence rates.
Parnn et al.13 reported that in Taiwan, hospital physicians
were more likely than clinic physicians to follow the
guidelines in treating AOM patients. It is not known,
however, whether physician nonadherence in clinics con-
tributes to higher recurrence rates among patients treated in
clinics. Interestingly, we noted that otolaryngological and
pediatric patients also had increased recurrence rates. We
speculated that the patients cared for by otolaryngology and
pediatric specialists had conditions that were more severe
than the conditions of those cared for by physicians with
other specialties. More studies are needed to test this
hypothesis and to make more specific interpretations.
Strengths and Limitations
Our study had several methodological strengths. First, we
used the NHI dataset, which is nationally representative
and with little risk of selection or recall bias, and there is a
low likelihood of lack of response and loss to follow-up of
cohort members. Second, the use of insurance claim data in
clinical research provides easy access to the longitudinal
records for a large sample of geographically dispersed
patients, which greatly increases the representativeness of
the study sample. Third, the large number of study subjects
also made it possible for us to perform analyses concerning
certain variables of interest including age, sex, physician’s
specialty, and hospital accreditation.
Our study also had the following limitations. The NHI
database is a useful data source for describing epidemiolo-
gical characteristics of AOM. However, findings from the
analysis of claims data can be limited by several factors and
should be interpreted with caution. First, the accuracy of
diagnostic coding from health care providers can affect the
validity of data. Since 2000, the BNHI has been using several
monitoring and cross-checking mechanisms to ensure the
accuracy of diagnostic coding. 8 Second, there were no
laboratory data or chart information available to determine
the disease severity of AOM, which might confound the
associations of recurrence with selected potential predictors
of interest observed in this study. Third, we defined ‘‘AOM
episode’’ as ‘‘all visits at least 14 days apart’’ to overcome
the maximum prescription restriction of 3 days for clinics
and 7 days for hospitals, but this may cause an under-
estimation of the actual incidence and recurrence of AOM.
CONCLUSION
Despite differences in incidence rates of AOM between
our study and findings from previous studies that are
mainly due to differences in diagnosis criteria, sampling
methods, observation intervals, and population character-
istics, we still found that AOM remains a major threat to
children’s health in Taiwan. A total of 283,084 children
,= 12 years of age sought treatment for AOM in 2006 in
Taiwan, representing an annual incidence rate of 64.5 per
1,000 children. We also found that the overall IDR of
recurrence was high at 33.5 per 100 PYs, which requires
attention from clinicians and health care administrators. We
therefore suggest that more intensive ontological care
should be delivered to children with elevated risk of
recurrence including males, those aged 0-2 years, those
treated at clinics, and those cared for by otolaryngologists or
pediatricians.
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